Opinion: New Docs – NIH Owns Half of Moderna Vaccine

0
770
Opinion section
Valley News - Opinion
Robert F. Kennedy, Jr., Chairman, Children’s Health Defense New documents obtained by Axios and Public Citizen suggest that the National Institute of Health (NIH) owns half the key patent for Moderna’s controversial COVID vaccine and could collect half the royalties. In addition, four NIH scientists have filed their own provisional patent application as co-inventors. Little known NIH regulations let agency scientists collect up to $150,000.00 annually in royalties from vaccines upon which they worked. These rules are recipes for regulatory corruption. NIH’s stake in the jab may explain why Anthony Fauci moved Moderna’s vaccine to the front of the line and to let Moderna skip animal trials despite the experimental technology and the inherent dangers of Coronaviru
Subscribe or log in to read the rest of this content.